Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft is currently managing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners and 3 distinct art units. This one-to-one ratio between actions, examiners, and art units indicates that every active matter is being handled by a different individual in a different administrative division. Such a spread suggests that the center's research output is diverse, triggering reviews from multiple specialized units within the USPTO rather than being clustered in a single niche.
CATHERINE LYNN MCCORMICK is the busiest examiner for this portfolio, with 1 pending office action. Since each of the 3 distinct examiners holds exactly one-third of the pending workload, no single examiner dominates the prosecution landscape. Practitioners must prepare for 3 separate sets of examiner preferences and art unit standards. This decentralized structure requires a versatile approach to Biotechnology & Pharmaceuticals claims, as the 3 distinct art units may apply varying levels of scrutiny. Coordinating responses across 3 distinct examiners requires careful attention to ensure that arguments made in one case do not inadvertently create issues for the other pending matters.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMICK, CATHERINE LYNN | 1 | 50.0% | +42.5% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
| ZHU, JIANJIAN | 1 | 58.8% | +82.4% |
| GONZALES, JOSEPHINE MARIA | 1 | 26.6% | +38.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18249511 | METHOD FOR NUCLEIC ACID DETECTION BY OLIGO HYBRIDIZATION AND PCR-BASED AMPLIFICATION | PARISI, JESSICA DANIELLE | 18d overdue |
| 18015489 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | ZHU, JIANJIAN | 11d overdue |
| 17372160 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | GONZALES, JOSEPHINE MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18249511 | METHOD FOR NUCLEIC ACID DETECTION BY OLIGO HYBRIDIZATION AND PCR-BASED AMPLIFICATION | PARISI, JESSICA DANIELLE | 18d overdue |
| 18015489 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | ZHU, JIANJIAN | 11d overdue |
| 18335765 | SELF-ORGANIZING NEURO-MUSCULAR JUNCTION CELL CULTURE MODEL | MCCORMICK, CATHERINE LYNN | — |
| 17372160 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | GONZALES, JOSEPHINE MARIA | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1638 | 1 |
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18335765 | SELF-ORGANIZING NEURO-MUSCULAR JUNCTION CELL CULTURE MODEL | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18249511 | METHOD FOR NUCLEIC ACID DETECTION BY OLIGO HYBRIDIZATION AND PCR-BASED AMPLIFICATION | PARISI, JESSICA DANIELLE | 1684 | §102§112 | Final Rejection | 18d overdue | Pending | Apr 18, 2023 |
| 18015489 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | ZHU, JIANJIAN | 1631 | §103§112Other | Final Rejection | 11d overdue | Pending | Jan 10, 2023 |
| 17372160 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Non-Final OA | — | Pending | Jul 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial